Company / EPS (Diluted)
Barinthus Biotherapeutics plc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.55
FY2025
5-year range
-$2.24 / $0.14
FY2021-FY2025
Trend
+18.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.14 to $-1.55 over the past 2 years.
Based on SEC 10-K filings.
-1.55 in FY2025.
Declined from $0.14 to $-1.55 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 18.8% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.55 | +18.8% |
| FY2024 | -$1.91 | -1464.3% |
| FY2023 | $0.14 | +107.1% |
| FY2022 | -$1.96 | +12.5% |
| FY2021 | -$2.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026